Anne Maria Wiencierz

Title: Anne Maria Wiencierz: Innovator in Cardiomyocyte Research

Introduction

Anne Maria Wiencierz is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of cardiomyocyte research, focusing on the enrichment and analysis of these vital heart cells. Her innovative work has implications for understanding heart diseases and developing new therapeutic strategies.

Latest Patents

Wiencierz holds a patent titled "Compositions of cardiomyocyte subpopulations." This invention provides the use of the antigens CD49e and/or CD49f as selection markers for the enrichment, isolation, detection, and analysis of atrial and ventricular cardiomyocytes. The patent also includes methods for isolating these cells from samples containing cardiomyocytes, along with substantially pure compositions of these cardiomyocyte subpopulations. She has 1 patent to her name.

Career Highlights

Anne Maria Wiencierz is associated with Miltenyi Biotec GmbH, a company known for its advancements in biotechnology and cell therapy. Her work at Miltenyi Biotec has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Dominik Eckardt and Andreas Bosio. Their collaborative efforts have further enhanced the research and development of cardiomyocyte-related technologies.

Conclusion

Anne Maria Wiencierz is a trailblazer in cardiomyocyte research, with her innovative patent paving the way for advancements in heart cell analysis and therapy. Her contributions are vital for the future of cardiac health and biotechnology.